Author Question: If a pharmaceutical company wished to design a drug to maintain low blood sugar (Read 553 times)

TI

  • Sr. Member
  • ****
  • Posts: 434
If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one approach might be to design a compound
A) that activates epinephrine receptors.
B) that increases cAMP production in liver cells.
C) to block G protein activity in liver cells.
D) that increases phosphorylase activity.
E) that keeps sugar molecules from crossing the plasma membrane of liver cells.



coco

  • Hero Member
  • *****
  • Posts: 739
In class, we found it was C. Good luck with the rest.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

TI

  • Sr. Member
  • ****
  • Posts: 434

 

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

Human kidneys will clean about 1 million gallons of blood in an average lifetime.

For a complete list of videos, visit our video library